OPDP Research Finds Disease Awareness Ads Could Confuse Consumers on Drug Risks and Benefits

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

OPDP Research Finds Disease Awareness Ads Could Confuse Consumers on Drug Risks and Benefits

J.W. Schomisch

July 26, 2024 at 02:51 PM EST

Two studies conducted by FDA Office of Pharmaceutical Drug Promotion (OPDP) found “the potential for disease awareness communications to confuse consumers regarding the benefits and risks of a drug.” A July Spotlight on CDER Science detailed two experiments that tested for conflation of fictitious disease awareness and prescription drug promotional communications in a televis... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

OPDP Research Finds Disease Awareness Ads Could Confuse Consumers on Drug Risks and Benefits

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT